NMAD
Lixte Biotechnology Holdings, Inc.
$6.93
+0.83 (+13.61%)
At close · Jul 8
Market Cap
$85.81M
Shares
12,382,944
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$200K
FY2015
Net Income
-$6.08M
-69.5%
FY2025
Operating Margin
-1323.21%
FY2015
Diluted EPS
-$1.26
+20.8%
FY2025
Operating Cash Flow
-$3.07M
+3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | $200K | — | $0 | $0 | $0 | $0 | — | — | — | — | |
| $496.84K | $254.92K | $726.23K | $898.1K | $1.35M | $1.74M | $1.22M | $820.91K | $40.7K | $467.26K | $870.01K | $2.09M | $1.12M | $879.89K | $1.01M | $1.33M | $445.54K | — | — | — | — | |
| $5.89M | $4.85M | $2.85M | $4.19M | $2.55M | $3.02M | $765.09K | $1.67M | $2.1M | $1.34M | $1.26M | $754.44K | $1.29M | $494.96K | $1.09M | $533.45K | $436.14K | — | — | — | — | |
| $6.39M | $5.11M | $3.57M | $5.09M | $6.31M | $6.72M | $3.27M | $2.49M | $2.14M | $1.81M | $2.13M | $2.85M | $2.4M | $1.37M | $2.11M | $1.87M | $881.68K | — | — | — | — | |
| -$6.39M | -$5.11M | -$3.57M | -$5.09M | -$6.31M | -$6.72M | -$3.27M | -$2.49M | -$2.14M | -$1.81M | -$2.13M | -$2.65M | -$2.4M | -$1.37M | -$2.11M | -$1.87M | -$881.68K | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | -1323.21% | — | — | — | — | — | — | — | — | — | |
| $9119 | $9158 | $16.82K | $16.23K | $8875 | $7414 | $3674 | — | — | — | — | — | — | $2469 | $0 | $0 | $0 | — | — | — | — | |
| — | $1600 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$7.36M | -$6.08M | -$3.59M | -$5.09M | -$6.31M | -$6.73M | -$3.26M | -$2.44M | -$2.13M | -$1.81M | -$2.13M | -$2.85M | -$2.77M | -$1.37M | -$3.58M | -$2.07M | -$880.25K | -$1.55M | -$1.27M | -$1.65M | -$562.08K | |
| — | — | — | — | — | — | — | — | — | — | — | -1426.05% | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | -$2.13M | -$2.85M | -$2.77M | — | — | — | — | — | — | — | — | |
| USD/shares | — | — | -$1.59 | -$2.66 | -$3.99 | -$5.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$1.26 | -$1.59 | -$2.66 | -$3.99 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | 2.25M | 1.92M | 1.58M | 1.35M | 1.13M | 1.12M | 5.88M | 5.58M | 4.79M | 4.68M | 4.44M | 4.16M | 3.9M | 3.52M | — | — | — | — | — |
| shares | — | 4.84M | 2.25M | 1.92M | 1.58M | 1.35M | 1.13M | 1.12M | 5.88M | 5.58M | 4.79M | 4.68M | 4.44M | 4.16M | 3.9M | 3.52M | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.